ATE319812T1 - Knochen-vorläufer-zellen: zusammensetzungen und methoden - Google Patents

Knochen-vorläufer-zellen: zusammensetzungen und methoden

Info

Publication number
ATE319812T1
ATE319812T1 AT95928831T AT95928831T ATE319812T1 AT E319812 T1 ATE319812 T1 AT E319812T1 AT 95928831 T AT95928831 T AT 95928831T AT 95928831 T AT95928831 T AT 95928831T AT E319812 T1 ATE319812 T1 AT E319812T1
Authority
AT
Austria
Prior art keywords
precursor cells
methods
bone precursor
bone
compositions
Prior art date
Application number
AT95928831T
Other languages
English (en)
Inventor
Michael W Long
Kenneth G Mann
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE319812T1 publication Critical patent/ATE319812T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95928831T 1994-08-12 1995-08-11 Knochen-vorläufer-zellen: zusammensetzungen und methoden ATE319812T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/289,794 US5972703A (en) 1994-08-12 1994-08-12 Bone precursor cells: compositions and methods

Publications (1)

Publication Number Publication Date
ATE319812T1 true ATE319812T1 (de) 2006-03-15

Family

ID=23113132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95928831T ATE319812T1 (de) 1994-08-12 1995-08-11 Knochen-vorläufer-zellen: zusammensetzungen und methoden

Country Status (7)

Country Link
US (3) US5972703A (de)
EP (1) EP0804551B1 (de)
AT (1) ATE319812T1 (de)
AU (1) AU712247B2 (de)
CA (1) CA2200197A1 (de)
DE (1) DE69534847T2 (de)
WO (1) WO1996005290A1 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719058A (en) * 1995-04-10 1998-02-17 Merck & Co., Inc. Method for producing a highly enriched population of osteoclast cells
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
ATE295875T1 (de) * 1996-03-01 2005-06-15 Isotis Nv Verfahren zur in vitro herstellung von knochen
US20040224300A1 (en) * 1997-01-24 2004-11-11 Shuji Terashima Method for separating nucleated cells
ATE218896T1 (de) 1997-07-16 2002-06-15 Isotis Nv Vorrichtung zur knochenbehandlung bestehend aus abbaubarem thermoplastischen copolyester und kultivierten zellen
US6576465B1 (en) * 1997-11-10 2003-06-10 The Regents Of The University Of Michigan Human bone accessory cells
WO1999028444A1 (en) 1997-12-02 1999-06-10 Zen Bio, Inc. Differentiation of adipose stromal cells into osteoblasts and uses thereof
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
IT1302534B1 (it) * 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
DE20023640U1 (de) * 1999-10-06 2005-06-23 Tigenix N.V. Isolierung von Vorläuferzellen und deren Verwendung zum Wiederaufbau von Bindegewebe
DE19956503A1 (de) * 1999-11-24 2001-06-21 Universitaetsklinikum Freiburg Spritzbares Knochenersatzmaterial
DK1234031T3 (en) 1999-11-30 2017-07-03 Mayo Foundation B7-H1, AN UNKNOWN IMMUNE REGULATORY MOLECULE
ES2304359T3 (es) * 1999-12-28 2008-10-16 The Regents Of The University Of Michigan Procedimiento de formacion ex vivo de hueso de mamiferos y usos del mismo.
US6811776B2 (en) 2000-12-27 2004-11-02 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
US20090233270A9 (en) * 2000-08-02 2009-09-17 St Croix Brad Secreted and cytoplasmic tumor endothelial markers
US20030228687A1 (en) * 2000-08-07 2003-12-11 The Regents Of The University Of Michigan Human bone accessory cells
US7435755B2 (en) * 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
US20030008328A1 (en) * 2001-07-03 2003-01-09 Wironen John F. Quantitative in vitro bone induction assay
ES2539105T3 (es) * 2001-07-06 2015-06-26 Asterias Biotherapeutics, Inc. Células mesenquimatosas y osteoblastos procedentes de células madre embrionarias humanas
AU2002226426A1 (en) * 2002-01-09 2003-07-24 Alberto Gorrochategui Barrueta Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements
US20070141036A1 (en) * 2002-01-09 2007-06-21 Alberto Gorrochategui Barrueta Composition and procedure for tissue creation, regeneration and repair by a cell-bearing biological implant enriched with platelet concentrate and supplements
EP1465615B1 (de) * 2002-01-15 2012-08-01 Trustees of Dartmouth College Trizyklische bisenon-derivate und verfahren zu ihrer verwendung
US7498040B2 (en) 2005-10-12 2009-03-03 Lifenet Health Compositions for repair of defects in osseous tissues, and methods of making the same
US7744597B2 (en) * 2002-06-26 2010-06-29 Lifenet Health Device and process for producing fiber products and fiber products produced thereby
US20040193274A1 (en) * 2003-03-28 2004-09-30 Trieu Hai H. Materials and methods for augmenting and/or repairing intervertebral discs
US7494811B2 (en) 2003-05-01 2009-02-24 Lifenet Health In vitro growth of tissues suitable to the formation of bone and bone forming tissue formed thereby
ES2491891T3 (es) 2004-01-16 2014-09-08 Carnegie Mellon University Marcaje celular para técnicas de resonancia magnética nuclear
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
CA2563518C (en) * 2004-04-23 2014-09-02 Bioe, Inc. Multi-lineage progenitor cells
PL1810026T3 (pl) 2004-10-06 2018-08-31 Mayo Foundation For Medical Education And Research B7-H1 i PD-1 w leczeniu raka nerkowokomórkowego
KR100702250B1 (ko) * 2005-06-13 2007-04-03 세원셀론텍(주) 피브린 혼합형 골절 유합용 반고형성 뼈세포 조성물 및이의 제조방법
WO2007038471A2 (en) * 2005-09-27 2007-04-05 Regenetech, Inc. Rotatable time varying electromagnetic force bioreactor and method of using the same
US20090215084A1 (en) * 2006-01-05 2009-08-27 Mayo Foundation For Medical Education And Research B7-h1 and b7-h4 in cancer
WO2007082144A2 (en) * 2006-01-05 2007-07-19 Mayo Foundation For Medical Education And Research B7-h1 and survivin in cancer
US8076136B2 (en) * 2006-03-30 2011-12-13 The United States Of America As Represented By The United States National Aeronautics And Space Administration Mineralized three-dimensional bone constructs
WO2007120911A2 (en) * 2006-04-14 2007-10-25 Carnegie Mellon University Cellular labeling and quantification for nuclear magnetic resonance techniques
WO2008054509A2 (en) * 2006-04-14 2008-05-08 Celsense, Inc. Methods for assessing cell labeling
US7727763B2 (en) * 2006-04-17 2010-06-01 Bioe, Llc Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
US8298528B2 (en) * 2006-04-17 2012-10-30 Hepacore Ltd. Methods for bone regeneration using endothelial progenitor cell preparations
WO2007124361A2 (en) * 2006-04-20 2007-11-01 Mayo Foundation For Medical Education And Research Soluble b7-h1
CA2670099A1 (en) * 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
WO2008064132A2 (en) * 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
EP2170975B1 (de) * 2007-07-10 2018-05-02 Carnegie Mellon University Zusammensetzungen und verfahren zur herstellung von zellmarkern für kernresonanztechniken
EP2192908A4 (de) * 2007-07-25 2010-09-01 Bioe Inc Differenzierung von vorläuferzellen mehrerer abstammung gegenüber chondrozyten
WO2009023845A2 (en) * 2007-08-15 2009-02-19 The Board Of Regents Of The University Of Texas System Combination therapy with synthetic triterpenoids and gemcitabine
WO2009064957A1 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc Development of a human colloidal bone graft material
WO2009064917A2 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc Generation of an hla-negative osteogenic precursor cell line
WO2009064956A1 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc A novel tissue culture platform for screening of potential bone remodeling agents
WO2009064958A1 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc Ex-vivo production of human demineralized bone matrix
KR101618380B1 (ko) * 2007-12-21 2016-05-04 본 테라퓨틱스 소시에테아노님 염증성 류마티스 질환의 치료에 있어서의 인간 골-형성 세포
EA022166B1 (ru) * 2008-01-11 2015-11-30 Ритэ Фамэсутиклс, Инк. Синтетические тритерпеноиды и их применение в лечении заболеваний
US20100278788A1 (en) * 2008-01-11 2010-11-04 Bone Therapeutics, S.A. Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
US20110020325A1 (en) * 2008-02-29 2011-01-27 Kwon Eugene D Methods for reducing granulomatous inflammation
CA2721665C (en) 2008-04-18 2017-01-24 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
US7943778B2 (en) 2008-04-18 2011-05-17 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
CN102083442B (zh) 2008-04-18 2014-08-13 里亚塔医药公司 抗氧化剂炎症调节剂：在c-17具有氨基和其它修饰的齐墩果酸衍生物
CN102164941B (zh) 2008-04-18 2015-05-27 里亚塔医药公司 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
US20110110863A1 (en) * 2008-05-02 2011-05-12 Celsense, Inc. Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
KR20110013450A (ko) 2008-05-07 2011-02-09 본 테라퓨틱스 소시에테아노님 간엽 줄기 세포 및 골-형성 세포
BE1018578A5 (fr) * 2008-05-07 2011-04-05 Bone Therapeutics Sa Cellules formatrices d'os humains dans le traitement d'etats et de maladies osseuses associes a une immunodeficience ou une immunosuppression.
US20110182866A1 (en) * 2008-05-15 2011-07-28 University Of Miami Isolation of stem cell precursors and expansion in non-adherent conditions
EP2294187A2 (de) * 2008-05-21 2011-03-16 BioE LLC Differenzierung von mehrlinien-vorläuferzellen zu pankreaszellen
US8314137B2 (en) * 2008-07-22 2012-11-20 Trustess Of Dartmouth College Monocyclic cyanoenones and methods of use thereof
JPWO2010021162A1 (ja) * 2008-08-19 2012-01-26 国立大学法人大阪大学 骨組織再生用の細胞製剤
WO2010077722A1 (en) * 2008-12-30 2010-07-08 Centocor Ortho Biotech Inc. Serum markers predicting clinical response to anti-tnf antibodies in patients with ankylosing spondylitis
ES2598006T3 (es) 2009-04-24 2017-01-24 Vanderbilt University Anticuerpos anti-TGF-beta para la inducción del crecimiento óseo
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
SG11201401434TA (en) 2011-10-11 2014-09-26 Bone Therapeutics Sa Uses of growth and differentiation factor 8 (gdf-8)
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
AU2013322604B2 (en) 2012-09-26 2018-01-18 Bone Therapeutics S.A. Formulations involving solvent/detergent-treated plasma (S/D plasma) and uses thereof
CA2902155C (en) 2013-02-22 2023-05-23 Lifenet Health Packaging assembly for storing tissue and cellular material
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
US10172911B2 (en) 2013-10-01 2019-01-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules
US10259875B2 (en) 2013-10-01 2019-04-16 Mayo Foundation For Medical Education And Research Methods for treating cancer in patients with elevated levels of BIM
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
JP2015097506A (ja) * 2013-11-19 2015-05-28 国立大学法人大阪大学 細胞表面マーカーをフローサイトメトリーで分析可能な骨芽細胞又は骨芽細胞に分化し得る細胞を得る方法
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2015179654A1 (en) 2014-05-22 2015-11-26 Mayo Foundation For Medical Education And Research Distinguishing antagonistic and agonistic anti b7-h1 antibodies
US10517875B2 (en) 2014-07-23 2019-12-31 Mayo Foundation for Medical Engineering and Research Targeting DNA-PKcs and B7-H1 to treat cancer
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
CA2977062A1 (en) * 2015-02-20 2016-08-25 Idexx Laboratories, Inc. Homogenous immunoassay with compensation for background signal
WO2016170112A1 (en) 2015-04-23 2016-10-27 Bone Therapeutics S.A. In vitro preservation of therapeutic cells
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017075045A2 (en) 2015-10-30 2017-05-04 Mayo Foundation For Medical Education And Research Antibodies to b7-h1
US11406721B2 (en) 2016-02-22 2022-08-09 The Regents Of The University Of California Compositions and methods for imaging cell populations
EP3464565A4 (de) 2016-05-25 2020-01-01 Terumo BCT, Inc. Zellexpansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3656842A1 (de) 2017-03-31 2020-05-27 Terumo BCT, Inc. Zellexpansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
AU2018351804B2 (en) 2017-10-20 2020-07-09 Bone Therapeutics Sa Methods for differentiating mesenchymal stem cells
WO2019099615A1 (en) 2017-11-17 2019-05-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of copeptin to modulate the immune response and hematopoiesis, and stimulate bone growth
KR20210074303A (ko) 2018-09-25 2021-06-21 본 테라퓨틱스 소시에테아노님 중간엽 줄기 세포의 분화 방법
WO2020229526A1 (en) 2019-05-13 2020-11-19 Bone Therapeutics Sa Improved lyophilized formulations involving hyaluronic acid and plasmatic proteins, and uses thereof
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5622853A (en) * 1990-05-01 1997-04-22 Becton Dickinson And Company T lymphocyte precursor
US5541072A (en) * 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
US5197985A (en) * 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2111845C (en) * 1991-06-18 2001-08-28 Arnold I. Caplan Monoclonal antibodies specific for marrow-derived mesenchymal cells
US5286642A (en) * 1992-06-24 1994-02-15 The Procter & Gamble Company Rat osteosarcoma cell line OSR5TR2
JPH08503198A (ja) * 1992-11-03 1996-04-09 クリエイティブ バイオモレキュルズ，インコーポレイテッド Ｏｐ−３誘導形態形成

Also Published As

Publication number Publication date
DE69534847D1 (de) 2006-05-04
DE69534847T2 (de) 2006-11-16
EP0804551A1 (de) 1997-11-05
US6740493B1 (en) 2004-05-25
US5972703A (en) 1999-10-26
AU712247B2 (en) 1999-11-04
CA2200197A1 (en) 1996-02-22
US7498170B2 (en) 2009-03-03
EP0804551B1 (de) 2006-03-08
AU3244295A (en) 1996-03-07
US20040214241A1 (en) 2004-10-28
WO1996005290A1 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
ATE319812T1 (de) Knochen-vorläufer-zellen: zusammensetzungen und methoden
DE69326082D1 (de) Kalzium phosphat als hydroxyapatit-vorläufer und verfahren zur herstellung und verwendung derselben
ATE478135T1 (de) Differenzierung in osteoblasten der fettgewebe- stromalen zellen und ihre verwendungen
MXPA04001334A (es) Materiales y metodos para promover la reparacion de tejido nervioso.
CO5130020A1 (es) Metodo para incrementar la dureza y tenacidad del hueso proceso para la manufactura de un medicamento que contiene una hormona paratiroide
DK0881908T3 (da) Anvendelse af fiberblastvækstfaktorer til stimulering af knoglevækst
NL7601628A (nl) Biologisch aanvaardbaar keramisch glas en toe- passing van het glas voor het vervaardigen van beenderprotesen, alsmede aldus verkregen protese.
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
BR0016058A (pt) Compostos de fosfonato
RS49780B (sr) Primena derivata fumarne kiseline u transplantacionoj medicini
DE19581649T1 (de) Biologisches Material und Knochenimplantat für die Wiederherstellung und den Austausch von Knochen
ATE295734T1 (de) Verwendung von fibroblasten-wachstumsfaktor analogen zur stimulation des knochenwachstums
ATE365045T1 (de) Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen,sowie damit verbundene zusammensetzungen und behandlungsformen
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
DE3690341D2 (en) Bone cement
CN106365630A (zh) 一种抗压强度和断裂韧性较好的生物陶瓷
TR200200278T2 (tr) Kalsilitik bileşimler
ATE342062T1 (de) Angiotensin ii zur verbesserung der befruchtung
AU2003293870A1 (en) Composite materials made of calcium compounds and polysaccharides containing glucuronic acid and/or iduronic acid
MX9704296A (es) Lineas celulares de condrocito.
Liu Novel high phosphate low fluoride containing bioactive glasses for hard and soft tissue repair
Block Discussion: Ridge augmentation using solid and porous hydroxylapatite particles with and without autogenous bone or plaster

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0804551

Country of ref document: EP

REN Ceased due to non-payment of the annual fee